Document ID: chunk:federal_register_of_legislation:F2025L00053:clause:1_5
Version: federal_register_of_legislation:F2025L00053
Segment Type: clause
Provision Reference: sch 1 cl 5
Character Range: 7412–8287

5  Schedule 1 (table)
After:
Ondansetron  Syrup 4 mg (as hydrochloride dihydrate) per 5 mL, 50 mL  Oral  Zofran syrup 50 mL  4 months stock by reference to usual PBS demand

insert:
Ondansetron  Tablet (orally disintegrating) 8 mg       Oral  Ondansetron ODT Viatris      after 31 May 2025—4 months stock by reference to usual demand of both Ondansetron ODT Viatris and Ondansetron Mylan ODT added together
Ondansetron  Tablet 4 mg (as hydrochloride dihydrate)  Oral  Ondansetron Tablets Viatris  after 31 May 2025—6 months stock by reference to usual demand of both Ondansetron Tablets Viatris and Ondansetron Mylan Tablets added together
Ondansetron  Tablet 8 mg (as hydrochloride dihydrate)  Oral  Ondansetron Tablets Viatris  after 31 May 2025—4 months stock by reference to usual demand of both Ondansetron Tablets Viatris and Ondansetron Mylan Tablets added together